Financial results - OMNIPRAX MEDICALS SRL

Financial Summary - Omniprax Medicals Srl
Unique identification code: 22872191
Registration number: J26/2163/2007
Nace: 8622
Sales - Ron
701.260
Net Profit - Ron
-5.337
Employee
13
The most important financial indicators for the company Omniprax Medicals Srl - Unique Identification Number 22872191: sales in 2023 was 701.260 euro, registering a net profit of -5.337 euro and having an average number of 13 employees. Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Omniprax Medicals Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 148.243 156.976 196.445 312.996 462.469 531.495 539.008 626.359 694.251 701.260
Total Income - EUR 148.343 160.320 196.627 313.076 462.480 531.517 539.017 629.114 695.108 701.287
Total Expenses - EUR 137.239 157.946 178.706 258.052 385.609 479.591 524.836 579.869 710.104 695.459
Gross Profit/Loss - EUR 11.104 2.373 17.921 55.024 76.871 51.926 14.182 49.245 -14.997 5.828
Net Profit/Loss - EUR 8.740 1.636 15.332 51.620 72.250 46.611 9.493 43.079 -21.517 -5.337
Employees 8 8 8 9 12 13 14 14 13 13
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales increased by 1.3%, from 694.251 euro in the year 2022, to 701.260 euro in 2023.

Check the financial reports for the company - Omniprax Medicals Srl

Rating financiar

Financial Rating -
Omniprax Medicals Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Omniprax Medicals Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Omniprax Medicals Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Omniprax Medicals Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Omniprax Medicals Srl - CUI 22872191

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 181 88 0 629 7.002 13.806 11.178 9.964 12.871 10.158
Current Assets 39.835 43.138 34.476 61.226 117.253 115.400 144.455 141.353 119.269 103.560
Inventories 0 0 0 0 0 0 0 0 912 1.203
Receivables 11.319 16.575 24.439 32.066 34.924 38.491 68.823 46.497 43.225 72.839
Cash 28.515 26.563 10.038 29.160 82.329 76.909 75.632 94.856 75.132 29.518
Shareholders Funds 27.131 28.994 15.387 51.673 116.188 115.519 118.470 133.280 9.507 4.142
Social Capital 45 45 45 44 43 42 41 40 41 40
Debts 12.884 14.232 19.089 10.182 12.364 15.794 42.331 18.036 122.633 109.576
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 103.560 euro in 2023 which includes Inventories of 1.203 euro, Receivables of 72.839 euro and cash availability of 29.518 euro.
The company's Equity was valued at 4.142 euro, while total Liabilities amounted to 109.576 euro. Equity decreased by -5.337 euro, from 9.507 euro in 2022, to 4.142 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Omniprax Medicals Srl

Comments - Omniprax Medicals Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.